Cryosite (CTE.AX) Hisse Fiyat
Cryosite Fiyat
Cryosite, son 19 yılda gelirini yıllık %6,9 artırarak 16,70 M AUD seviyesine taşıdı. Hisse başına kâr, son 19 yılda yıllık %4,1 büyüdü. Cryosite için net marj, %13,4 ile birkaç yıl önceki %11,6 seviyesine göre yükseldi. Bugünkü fiyata göre temettü verimi kabaca %1,66 seviyesine denk geliyor. Temettü dağıtım oranı, kârın yaklaşık %91 düzeyindedir. Temettü, son 13 yılda yıllık %5,5 artış gösterdi.
Cryosite hisse senedi fiyatı
Cryosite iş modeli ve hisse analizi
Cryosite hakkında sık sorulan sorular
The business model of Cryosite Ltd focuses on providing biobanking and cell therapy services. Cryosite specializes in the collection, storage, and distribution of human biological samples such as cord blood, tissue, and cells for medical and research purposes. The company allows individuals and families to preserve cord blood stem cells for potential future use in regenerative medicine. Cryosite also offers cell therapy manufacturing services to support personalized medicine and clinical trials. With its expertise and advanced technology, Cryosite aims to contribute to advancements in medical treatments and research, offering peace of mind to those seeking to preserve their biological materials.
Cryosite Ltd is primarily active in the biomedical and life sciences industries.
The main competitors of Cryosite Ltd in the market are companies like Stemlife, Singapore Cord Blood Bank, and CordLife Group Limited.
Cryosite Ltd, a reputable Australian company, has an intriguing history and background. Established in 2000, Cryosite has played a pivotal role in the field of biomedical services. The company specializes in secure storage and transportation of precious biological samples, supporting medical research, clinical trials, and stem cell transplant programs. With state-of-the-art facilities and stringent quality control measures, Cryosite has gained recognition as a trusted partner for numerous healthcare institutions and research organizations globally. Over the years, Cryosite Ltd has showcased its expertise in preserving and managing these life-changing resources, contributing significantly to advancements in healthcare and cutting-edge research.
Cryosite Ltd has achieved several significant milestones. Firstly, the company successfully established itself as a leading provider of comprehensive storage solutions for stem cells, reproductive tissues, and cord blood in Australia. Additionally, Cryosite Ltd expanded its services by offering advanced cryopreservation techniques, ensuring the long-term viability of stored materials. The company's commitment to quality led to accreditation by the Therapeutic Goods Administration (TGA) and attainment of ISO 9001 certification. Furthermore, Cryosite Ltd expanded its client base, attracting partnerships with major healthcare institutions and research organizations. These milestones demonstrate Cryosite Ltd's success in delivering trusted and state-of-the-art cryogenic storage services to its clients.
Cryosite Ltd primarily operates in Australia and New Zealand.
Cryosite Ltd is a leading company that values integrity, reliability, and innovation. With a strong corporate philosophy focused on providing premium services and solutions in the field of biobanking and reproductive services, Cryosite is committed to excellence. The company strives to ensure the utmost trust and transparency in all its operations, delivering high-quality cryopreservation services, cord blood banking, and stem cell research facilities. Cryosite Ltd continuously pushes boundaries through cutting-edge technology and strategic partnerships, aiming to meet the evolving needs of its customers and make a positive impact in the healthcare industry.
Güncel döviz kuruyla Cryosite hissesi 0,75 EUR (1,21 AUD) seviyesindedir.
Cryosite hissesi (CTE.AX) 1 borsada işlem görür, bunlar arasında: ASX (CTE.AX).
Cryosite Ltd is an Australian company that has been operating in the field of biological material storage for over 15 years. With a wide range of services and products, the company has established itself as a leading provider of cryo-storage solutions in Australia.
'nin Cryosite hasılatı 16,70 M AUD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
'nin Cryosite karı 2,24 M AUD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Cryosite'nin Fiyat/Kazanç (F/K) oranı şu anda 28,14'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Cryosite hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Cryosite'nin Fiyat/Satış (F/S) oranı şu anda 3,77'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Cryosite hisse senedinin değerleme metriği olarak hizmet eder.
Cryosite'nin Eulerpool Kalite Puanı 5/10'dur.
Cryosite'nin ISIN'i AU000000CTE1'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Cryosite'nin WKN'i 621943'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Cryosite'nin ticker'ı CTE.AX'dir. Ticker sembolü, Cryosite hisseleri borsada işlem görmek için kullanılır.
Cryosite Hissesi
Cryosite Emsaller Grubu
Cryosite Ticker
Cryosite FIGI
Cryosite'nin tüm temel göstergeleri ve derinlemesine analizi
Cryosite hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Cryosite şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: